Africa Bioinformatics Market Report 2022 to 2030

Africa Bioinformatics Market Analysis

$ 3999

The Africa Bioinformatics market is projected to grow from $230.25 Mn in 2022 to $853.81 Mn by 2030, registering a CAGR of 17.80% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in investments from the public and private sectors, the growing healthcare industry, and technological advancements. The market is segmented by technology and by application. Some of the major players include IBM Life Sciences, Qiagen, NEC, Thermo Fisher Scientific, and Agilent Technologies.

ID: IN10AFHS001 CATEGORY: Healthcare Services GEOGRAPHY: Africa AUTHOR: Neha Davda

Buy Now

Africa Bioinformatics Market Executive Summary

The Africa Bioinformatics market is projected to grow from $230.25 Mn in 2022 to $853.81 Mn by 2030, registering a CAGR of 17.80% during the forecast period of 2022 - 2030. Africa's healthcare spending varies greatly from country to country. Healthcare spending varies greatly between nations, with some, like South Africa, having relatively high levels while others, like many low-income nations, have very low levels. By African standards, South Africa spent a relatively high 8.5% of its GDP on healthcare.

The field of bioinformatics, which combines biology with information technology, connects biological data with methods for information storage, distribution, and analysis to serve a variety of scientific fields, including biomedicine. It makes use of software tools for data management, data warehousing, data mining, and other functions. Exploiting such data produces scientific findings that are applied to the study of genetics and genomes. The bioinformatics market in Africa is rapidly growing and the market is dominated by South Africa.

africa bioinformatics market analysis

Market Dynamics

Market Growth Drivers

Africa's bioinformatics industry is expanding significantly, and this development is being fueled by a variety of factors. First of all, governments and organizations from the private sector are boosting investment in the healthcare sector, including bioinformatics, as more people in Africa are becoming aware of its significance. Secondly, the demand for bioinformatics goods and services is being driven by the growing need for improved healthcare solutions to address public health issues including infectious diseases. Also, the use of bioinformatics tools and applications in Africa is growing due to technological improvements like the widespread use of smartphones and the internet.

Market Restraints

Limited infrastructure, high cost of research and development in this field and shortage of skilled personnel limits the growth of bioinformatics in the region. Additionally, the absence of standardization and regulations in the industry is hindering market expansion, making it challenging for businesses to run and for consumers to make wise purchasing decisions.

Competitive Landscape

Key Players

IBM Life Sciences
Qiagen
NEC
Thermo Fisher Scientific
Agilent Technologies

Notable Recent Deals

July 2019: NEC announced the acquisition of OncoImmunity, a bioinformatics company that develops specialized machine learning software to aid in the fight against cancer. The resources and capabilities that support the development of its pipelines for customized immunotherapy needed to be strengthened by this acquisition. NEC will continue to prioritize drug discovery while NEC OncoImmunity AS will continue to offer its neoantigen prediction services.

Healthcare Policies and Regulatory Landscape

The regulatory environment for bioinformatics in Africa can vary significantly by country and have an impact on the development and application of bioinformatics solutions. In South Africa's public and private healthcare systems, the government sponsors the vast majority of healthcare providers. The National Department of Health (NDoH) is responsible for establishing healthcare laws and regulations in South Africa.

In Egypt also, government sponsors the majority of healthcare providers. The Ministry of Health and Population is responsible for establishing healthcare rules and regulations in Egypt. According to the 2016-passed Universal Health Insurance Law, all Egyptians are meant to obtain universal health coverage (UHIL). Everybody must enroll in one of the three government-sponsored health insurance programs as required by law.

Reimbursement Scenario

In Africa, there are few reimbursement rules for healthcare services, and patients typically pay the majority of healthcare costs out of pocket. Many people, especially in rural and low-income areas, may not be able to afford healthcare services due to the restricted availability of insurance and other payment options. There are certain nations in the region where the government reimburses patients in full or in part for specific healthcare services. Rural areas have fewer access to reimbursement choices, and there are frequent inequalities in reimbursement between urban and rural locations.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.